Finnadvance is a microtechnology and 3D biology solution company based in Oulu, Finland. Finnadvance is developing microfluidic

organ-on-chips for pharmaceutical drug research and development. ​

Microfluidics and microtechnology solutions

In the human body cells form different tissues, which have different mechanical properties. These mechanical cues in the local environment of the cells give rise to unique biochemical response either via extracellular matrix (ECM) production or by cell signaling. In routine cell biology studies, cells are grown on various different surfaces like polypropylene, polystyrene and glass. It has been long known that the cell morphology observed in vivo is not reflected in these culture conditions.

Finnadvance’s microfluidic approach enables replicating precise biomechanical stimuli in vitro, with precise control of flow velocities and 3D ECM stiffness. With our microfluidic culture systems, we aim to close the gap between in vitro studies and in vivo results. Our devices are fully integrated microfluidics solutions compatible with microscope/imaging systems.

We undertake custom chip design and fabrication projects for specific applications. Challenge us!

News Highlights at Finnadvance

April 29, 2020

Finnadvance completes 550k€ seed round led by Voima Ventures and Finnish biotech business angels

February 29, 2020

Finnadvance part of Finland’s efforts on nanobiotechnology derived therapeutics

July 05, 2018

Significant EU-funding for the research of vascular anomalies

Open Positions

science@finnadvance.com

+358 40 653 7049

Aapistie 5A, Oulu, Finland

  • LinkedIn
  • Twitter

©2020 Finnadvance